These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27802241)

  • 1. Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
    Nunomura A; Zhu X; Perry G
    J Alzheimers Dis; 2017; 55(1):73-75. PubMed ID: 27802241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.
    Kitamura Y; Inden M; Kimoto Y; Takata K; Yanagisawa D; Hijioka M; Ashihara E; Tooyama I; Shimohama S; Ariga H
    J Alzheimers Dis; 2017; 55(1):67-72. PubMed ID: 27662308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
    Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
    Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
    Hong Z; Shi M; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Zabetian CP; Leverenz JB; Baird G; Montine TJ; Hancock AM; Hwang H; Pan C; Bradner J; Kang UJ; Jensen PH; Zhang J
    Brain; 2010 Mar; 133(Pt 3):713-26. PubMed ID: 20157014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats.
    Kitamura Y; Watanabe S; Taguchi M; Takagi K; Kawata T; Takahashi-Niki K; Yasui H; Maita H; Iguchi-Ariga SM; Ariga H
    Mol Neurodegener; 2011 Jul; 6(1):48. PubMed ID: 21740546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
    Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
    Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
    Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
    Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
    Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
    J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
    Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
    J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
    Ooe H; Iguchi-Ariga SM; Ariga H
    Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits.
    Solti K; Kuan WL; Fórizs B; Kustos G; Mihály J; Varga Z; Herberth B; Moravcsik É; Kiss R; Kárpáti M; Mikes A; Zhao Y; Imre T; Rochet JC; Aigbirhio F; Williams-Gray CH; Barker RA; Tóth G
    Neurobiol Dis; 2020 Feb; 134():104629. PubMed ID: 31669752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.
    Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC
    J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
    Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
    J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
    Hijioka M; Inden M; Yanagisawa D; Kitamura Y
    Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene diagnosis of Alzheimer's disease and Parkinson's disease].
    Tanaka S
    Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.
    Shi M; Zabetian CP; Hancock AM; Ginghina C; Hong Z; Yearout D; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Leverenz JB; Zhang J
    Neurosci Lett; 2010 Aug; 480(1):78-82. PubMed ID: 20540987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.